PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 1 filers reported holding PROVENTION BIO INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $20,824,353 | +798.5% | 864,081 | +294.1% | 0.01% | +400.0% |
Q4 2022 | $2,317,683 | +228468.3% | 219,270 | -2.7% | 0.00% | – |
Q3 2022 | $1,014 | -25.8% | 225,323 | -34.1% | 0.00% | – |
Q2 2022 | $1,367 | -99.9% | 341,711 | +40.2% | 0.00% | – |
Q1 2022 | $1,783,000 | +17.7% | 243,691 | -9.6% | 0.00% | – |
Q4 2021 | $1,515,000 | +13.1% | 269,580 | +28.8% | 0.00% | – |
Q3 2021 | $1,339,000 | -52.2% | 209,237 | -37.1% | 0.00% | -100.0% |
Q2 2021 | $2,804,000 | -21.5% | 332,600 | -2.3% | 0.00% | 0.0% |
Q1 2021 | $3,573,000 | +189.1% | 340,506 | +366.5% | 0.00% | – |
Q4 2020 | $1,236,000 | -28.1% | 72,989 | -45.5% | 0.00% | – |
Q3 2020 | $1,719,000 | +14.3% | 133,917 | +25.6% | 0.00% | – |
Q2 2020 | $1,504,000 | +56.8% | 106,615 | +2.3% | 0.00% | – |
Q1 2020 | $959,000 | +2563.9% | 104,240 | +562.8% | 0.00% | – |
Q1 2019 | $36,000 | +2.9% | 15,727 | -20.3% | 0.00% | – |
Q4 2018 | $35,000 | -60.2% | 19,735 | -9.9% | 0.00% | – |
Q3 2018 | $88,000 | – | 21,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DG Capital Management, LLC | 417,092 | $5,351,000 | 3.22% |
Johnson & Johnson Innovation - JJDC, Inc. | 574,973 | $7,377,000 | 1.48% |
Soleus Capital Management, L.P. | 139,418 | $1,789,000 | 0.95% |
683 Capital Management, LLC | 859,314 | $11,025,000 | 0.81% |
Perceptive Advisors | 4,265,711 | $54,729,000 | 0.80% |
GILDER GAGNON HOWE & CO LLC | 2,151,402 | $27,602,000 | 0.17% |
Virtus ETF Advisers LLC | 21,485 | $276,000 | 0.14% |
RICE HALL JAMES & ASSOCIATES, LLC | 230,873 | $2,962,000 | 0.12% |
Windsor Creek Advisors, LLC | 28,492 | $366,000 | 0.10% |
Newbridge Financial Services Group, Inc. | 6,500 | $83,000 | 0.08% |